Latest Market News
US CPI Up NextLooking ahead to today’s US session and the key focus will be the release of US CPI for March. In light of hawkish comments from various Fed members last week, as well as further hawkish details in the FOMC minutes, today’s data holds the power to drive USD further higher. In terms […]
Pledge has also introduced a mechanism allowing each crypto transaction to contribute to verified carbon offset initiatives via the United Nations Climate Neutral Now Initiative. 772 Total views 32 Total shares Fundraising platform Pledge has launched PledgeCrypto to allow nonprofits to accept crypto donations in more than 130 cryptocurrencies — including Bitcoin (BTC), Ether (ETH) […]
San Francisco-based insurance technology provider Newfront said Tuesday its valuation now tips the scale at $2.2 billion with a $200 million investment from the growth equity business within Goldman Sachs Asset Management and B Capital, with participation from existing investors including Founders Fund and Meritech Capital. Newfront, which employs 800 people and operates an insurance […]
Current and former employees of P&O are urged not to make any quick decisions about their pension following recent media reports. The Financial Conduct Authority (FCA), the Pensions Regulator (TPR) and the Money and Pensions Service (MaPS) are raising their concerns given the heightened risk of pension transfers following recent redundancies. The FCA and TPR […]
A new study has revealed staggering growth in crypto adoption across Nigeria, fueled by limited access to affordable fiat-based financial services in Africa. Crypto exchange KuCoin’s “Into the Cryptoverse Report” highlights that many Nigerian citizens have started using cryptocurrencies as a viable alternative to store and transfer assets. According to the report, 35% of the […]
The Food and Drug Administration’s decision on Monday to lift the partial hold on Gilead Sciences Inc.’s GILD, -0.66% magrolimab for two indications is “good news” for the company, according to RBC Capital Markets analysts. “While GILD still has much to prove around its emerging oncology franchise, we see this as a much-needed piece of […]